Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low vs Standard Dose Triamcinolone Acetonide for Knee Osteoarthritis
NCT06782529Phase 4Recruiting
- Sponsor
- Mayo Clinic
- Start
- Jan 2025
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone acetonide in osteoarthritis of the knee (OA), sponsored by Mayo Clinic. Started Jan 2025; status: recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
osteoarthritis of the knee (OA)
Beyond the preview
Go deeper on NCT06782529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06782529.